| Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor -> Monitor Keywords |
|
|
 
Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses thereforRelated Patent Categories: Chemistry: Molecular Biology And Microbiology, Micro-organism, Tissue Cell Culture Or Enzyme Using Process To Synthesize A Desired Chemical Compound Or Composition, Recombinant Dna Technique Included In Method Of Making A Protein Or PolypeptideStable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor description/claimsThe Patent Description & Claims data below is from USPTO Patent Application 20070190603, Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor. Brief Patent Description - Full Patent Description - Patent Application Claims
RELATED APPLICATION [0001] This application is a continuation of U.S. Ser. No. 10/390,472, filed Aug. 29, 2006, now U.S. Pat. No. 7,098,028, which is a continuation of U.S. Ser. No. 08/824,513, filed Mar. 26, 1997, now U.S. Pat. No. 6,800,481, which is a continuation of U.S. Ser. No. 08/293,284, filed Aug. 22, 1994, now U.S. Pat. No. 5,955,343, which is a Continuation-in-Part of U.S. Ser. No. 07/973,326, filed Dec. 28, 1992, now abandoned, all of which are incorporated herein by reference. BACKGROUND [0003] Macroscopic membranes play an important role in many biological processes at both the cellular and organismic level. In addition, membranes are used in a number of medical, research, and industrial applications. Physiologically compatible membranes would be especially valuable for biomedical products. At present, the self-assembly of peptides into macroscopic membranes has not been reported. SUMMARY OF THE INVENTION [0004] The invention relates to the discovery that a new class of biomaterials derived from peptides related to the yeast DNA binding protein zuotin. The oligopeptides are generally stable in aqueous solutions and self-assemble into large, extremely stable macroscopic structures or matrices when exposed to physiological levels of salt. The biomaterials are visible to the naked eye when stained with a dye, Congo Red, and can form sheet-like or fibril structures which have high tensile strength. These materials are substantially resistant to change in pH, heat, and enzymatic proteolysis. The biomaterials can have a fibrous microstructure with small pores as revealed by electron microscopy. [0005] A small peptide termed EAK16 (AEAEAKAKAEAEAKAK, aa 310-325 of SEQ ID NO: 2) was discovered serendipitously to self-assemble into stable macroscopic membranes and filaments in the presence of millimolar concentrations of salt. This invention relates to the self-assembly of peptides into stable macroscopic membranes and filaments. Peptides which form membranes are characterized as being amphiphilic, e.g., having alternating hydrophobic and hydrophilic amino acid residues; greater than 12 amino acids, and preferably at least 16 amino acids; complementary and structurally compatible. Complementary refers to the ability of the peptides to interact through ionized pairs and/or hydrogen bonds which form between their hydrophilic side-chains, and structurally compatible refers to the ability of complementary peptides to maintain a constant distance between their peptide backbones. Peptides having these properties participate in intermolecular interactions which result in the formation and stabilization of .beta.-sheets at the secondary structure level and interwoven filaments at the tertiary structure level. [0006] Both homogeneous and heterogeneous mixtures of peptides characterized by the above-mentioned properties can form stable macroscopic membranes and filaments. Peptides which are self-complementary and self-compatible can form membranes in a homogeneous mixture. Heterogeneous peptides, including those which cannot form membranes in homogeneous solutions, which are complementary and/or structurally compatible with each other can also self-assemble into macroscopic membranes and filaments. [0007] Peptides which can self-assemble into macroscopic membranes and filaments, the conditions under which membrane and filament formation occurs, and methods for producing the membranes and filaments are described and included in this invention. [0008] Macroscopic membranes and filaments formed of the peptide EAK16 have been found to be stable in aqueous solution, in serum, and in ethanol and are highly resistant to degradation by heat, alkaline and acidic pH (i.e., stable at pH 1.5-11), chemical denaturants (e.g., guanidine-HCl, urea and sodium dodecyl sulfate), and proteases in vitro (e.g., trypsin, .alpha.-chymotrypsin, papain, protease K, and pronase). The membranes and filaments have also been found to be non-cytotoxic. The membranes are thin, transparent and resemble high density felt under high magnification. Being composed primarily of protein, the membranes and filaments can be digested and metabolized in animals and people. They have a simple composition, are permeable, and are easy and relatively inexpensive to produce in large quantities. The membranes and filaments can also be produced and stored in a sterile condition. Thus, the macroscopic membranes and filaments provided by this invention are potentially useful as biomaterial for medical products, as vehicles for slow-diffusion drug delivery, as separation matrices, for supporting in vitro cell attachment and growth, for supporting artificial tissue, e.g., for in vivo use, and for other uses requiring permeable and water-insoluble material. [0009] Furthermore, the salt-induced assembly of the peptides into insoluble and protease-resistant protein filaments with a .beta.-sheet secondary structure is similar in some respects to the formation of the neurofibrillary filaments and amyloid plaques associated with Alzheimer's disease and the formation of scrapie prion protein filaments liver cirrhosis, kidney amyloidosis, and other protein confirmational diseases. The formation of the macroscopic membranes and filaments can, therefore, be useful as a model system, e.g. to study these pathological processes. For example, such a model system can be used to identify drugs which inhibit filament formation and are thus useful for treating Alzheimer's disease and scrapie infection. [0010] Peptide EAK16 was derived from a region of a yeast protein, zuotin, which exhibits a high affinity for DNA in the left-handed Z conformation. Zuotin was identified by a gel shift assay for Z-DNA binding proteins developed by the Applicants. Applicants further cloned and sequenced the gene encoding zuotin. Characterization of zuotin revealed that the protein is a potential substrate for several protein kinases and identified a putative DNA-binding domain. This invention also includes all or biologically active portions of the zuotin protein and DNA encoding zuotin. BRIEF DESCRIPTION OF THE DRAWINGS [0011] FIG. 1 shows the amino acid sequence of zuotin (SEQ ID NO: 2) and a number of features of this protein. [0012] FIG. 2 is a restriction map of the wild type ZUO1 locus and the URA3::zuo1 disrupted locus. [0013] FIGS. 3a, 3b, 3c, 3d, 3e, 3f, 3g and 3h are serial photographs of membranes under scanning electron microscopy (SEM). [0014] FIG. 4 is the typical .beta.-sheet circular dichroism spectrum of the EAK16 peptide. [0015] FIGS. 5A-5C show the hypothetical interactions between EAK16 molecules in the membranes and the secondary and tertiary structures resulting therefrom. [0016] FIG. 6 illustrates calculation of the inter-peptide distance of ionized and hydrogen bonding amino acid pairs. [0017] FIG. 7A illustrates the self-complementarity and self-compatibility of a peptide (SEQ ID NO: 19). [0018] FIG. 7B illustrates staggering of interacting peptides. [0019] FIG. 7C illustrates peptide interactions in a heterogeneous mixture (SEQ ID NO: 20and 21). [0020] FIGS. 8A and 8B show the stability of the .beta.-sheet structure of peptide EAK16 in water at different peptide concentrations. [0021] FIGS. 9A and 9B show the thermal stability of the .beta.-sheet structure of EAK16. Continue reading about Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor... Full patent description for Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor Brief Patent Description - Full Patent Description - Patent Application Claims Click on the above for other options relating to this Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor patent application. ###  How KEYWORD MONITOR works... a FREE service from FreshPatents1. Sign up (takes 30 seconds). 2. Fill in the keywords to be monitored. 3. Each week you receive an email with patent applications related to your keywords. Start now! - Receive info on patent apps like Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor or other areas of interest. ### Previous Patent Application: Nucleic acid encoding an interleukin-9 receptor variant Next Patent Application: Thermostable alpha-amylases Industry Class: Chemistry: molecular biology and microbiology ### FreshPatents.com Support Thank you for viewing the Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor patent info. IP-related news and info Results in 0.28546 seconds Other interesting Feshpatents.com categories: Accenture , Agouron Pharmaceuticals , Amgen , AT&T , Bausch & Lomb , Callaway Golf 174 |
 * Protect your Inventions * US Patent Office filing 
PATENT INFO |
|
